(Q30350063)

20 June 2017

1 reference

title

The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy? (English)

1 reference

20 June 2017

1 reference

Paul Dorian

1

1 reference

20 June 2017

Iqwal Mangat

series ordinal

2

1 reference

20 June 2017

Arnold Pinter

series ordinal

3

1 reference

20 June 2017

Victoria Korley

series ordinal

4

1 reference

20 June 2017

language of work or name

1 reference

1 December 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

20 June 2017

published in

1 reference

20 June 2017

volume

9

1 reference

20 June 2017

issue

4

1 reference

20 June 2017

page(s)

257-262

1 reference

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Antithrombotic therapy for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Potential ionic mechanism for repolarization differences between canine right and left atrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900405

10.1177/107424840400900405

21 January 2018

Identifiers

DOI

1 reference

20 June 2017

1 reference